Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.502,08
-0,33%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Skye Bioscience Inc (SKYE) Skye Bioscience Inc (SKYE) Notizie

SKYE

Skye Bioscience (SKYE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SKYE
DataOraFonteTitoloSimboloCompagnia
20/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SKYESkye Bioscience Inc
17/05/202422:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SKYESkye Bioscience Inc
10/05/202422:19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SKYESkye Bioscience Inc
10/05/202422:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SKYESkye Bioscience Inc
17/06/201015:00MarketwiredMarshall Edwards Announces Additional Management Changes With Appointment of New Chief Financial OfficerNASDAQ:SKYESkye Bioscience Inc
25/03/201008:16MarketwiredSkyePharma PLC announces Final ResultsNASDAQ:SKYESkye Bioscience Inc
21/01/201016:59MarketwiredSkyepharma PLC announces - Regulatory UpdateNASDAQ:SKYESkye Bioscience Inc
18/11/200908:00MarketwiredSkyepharma PLC - Board ChangeNASDAQ:SKYESkye Bioscience Inc
12/11/200908:00MarketwiredSkyepharma PLC - Interim Management StatementNASDAQ:SKYESkye Bioscience Inc
02/11/200911:23MarketwiredFlutiform EU Clinical Trial Successfully CompletedNASDAQ:SKYESkye Bioscience Inc
01/09/200908:00MarketwiredSKYEPHARMA PLC - Research UpdateNASDAQ:SKYESkye Bioscience Inc
22/06/200916:42MarketwiredSkyepharma PLC announces Conversion of BondsNASDAQ:SKYESkye Bioscience Inc
09/06/200916:14MarketwiredSkyepharma PLC Announces Research UpdateNASDAQ:SKYESkye Bioscience Inc
22/05/200908:09MarketwiredSkyePharma PLC: Flutiform NDA Accepted for ReviewNASDAQ:SKYESkye Bioscience Inc
15/05/200908:03MarketwiredSkyepharma PLC announces Board AppointmentNASDAQ:SKYESkye Bioscience Inc
15/05/200908:00MarketwiredSkyepharma Announces Interim Management StatementNASDAQ:SKYESkye Bioscience Inc
31/03/200908:17MarketwiredSkyepharma - Re AgreementNASDAQ:SKYESkye Bioscience Inc
26/03/200908:05MarketwiredSkyepharma PLC Announces Final ResultsNASDAQ:SKYESkye Bioscience Inc
23/03/200908:00MarketwiredSkyepharma PLC Announces Regulatory ApplicationNASDAQ:SKYESkye Bioscience Inc
06/03/200913:57MarketwiredSkyepharma PLC announces Conversion of BondsNASDAQ:SKYESkye Bioscience Inc
05/03/200914:44MarketwiredSkyepharma PLC announces Consultation ProcessNASDAQ:SKYESkye Bioscience Inc
21/01/200908:00MarketwiredResearch UpdateNASDAQ:SKYESkye Bioscience Inc
07/01/200908:00MarketwiredSkyepharma PLC announces European Product ApprovalNASDAQ:SKYESkye Bioscience Inc
19/12/200808:07MarketwiredSkyepharma - Update on Formoterol CertihalerNASDAQ:SKYESkye Bioscience Inc
11/12/200810:59MarketwiredSkyepharma PLC - Research UpdateNASDAQ:SKYESkye Bioscience Inc
25/11/200812:41MarketwiredSkyepharma-PiperJaffray 2008 HealthCare ConferenceNASDAQ:SKYESkye Bioscience Inc
27/10/200808:07MarketwiredSkyepharma announces Interim Management StatementNASDAQ:SKYESkye Bioscience Inc
23/10/200808:00MarketwiredSkyepharma - Research UpdateNASDAQ:SKYESkye Bioscience Inc
03/10/200812:02MarketwiredSkyepharma - Statement re Convertible BondsNASDAQ:SKYESkye Bioscience Inc
28/08/200808:00MarketwiredSkyePharma PLC -- Interim ResultsNASDAQ:SKYESkye Bioscience Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SKYE

La tua Cronologia

LSE
38DR
Thames W.u.47
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network